Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 5-HT2C receptor is a subtype of the serotonin (5-hydroxytryptamine, 5-HT) receptors, specifically within the 5-HT2 family. It is a GPCR that primarily couples to Gq/G11 proteins and mediates excitatory neurotransmission. The human gene encoding this receptor is HTR2C, located on the X chromosome. It plays significant roles in regulating mood, anxiety, feeding behavior, and reproductive behavior. Therapeutic interest includes drugs for obesity management, migraine treatment, psychiatric disorders, and substance use disorder therapies.
Modulates intracellular signaling cascades through Gq/G11-mediated pathways leading to increased intracellular calcium levels; Inhibition of dopamine and norepinephrine release
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-hydroxytryptamine receptor 2C (5-HT2C).